Casdin Capital, LLC Diversified Active

CIK: 0001534261 · Show all filings

Period: Q4 2017 (← Previous) (Next →)

Filing Date: Feb 14, 2018

Total Value ($000): $410,635 (100.0% shares, 0.0% debt)

Holdings (27)

— SAGE THERAPEUTICS INC 10.0%

Value ($000) $41,178 Shares 250,000 Est. Cost $52.53 Unrealized —

— FOUNDATION MEDICINE INC 8.6%

Value ($000) $35,464 Shares 520,000 Est. Cost $22.74 Unrealized —

— LOXO ONCOLOGY INC 7.4%

Value ($000) $30,305 Shares 360,000 Est. Cost $28.44 Unrealized —

— BLUEPRINT MEDICINES CORP 6.4%

Value ($000) $26,243 Shares 348,000 Est. Cost $37.87 Unrealized —

— BLUEBIRD BIO INC 6.3%

Value ($000) $25,825 Shares 145,000 Est. Cost $115.06 Unrealized —

ALNY ALNYLAM PHARMACEUTICALS INC 6.2%

Value ($000) $25,410 Shares 200,000 Est. Cost $73.35 Unrealized +71.3%

— MYOKARDIA INC 5.7%

Value ($000) $23,576 Shares 560,000 Est. Cost $22.11 Unrealized —

SGMO SANGAMO THERAPEUTICS INC 5.6%

Value ($000) $22,960 Shares 1,400,000 Est. Cost $4.96 Unrealized +200.2%

— GLOBAL BLOOD THERAPEUTICS IN 4.9%

Value ($000) $20,265 Shares 515,000 Est. Cost $29.83 Unrealized —

VYGR VOYAGER THERAPEUTICS INC 4.6%

Value ($000) $18,841 Shares 1,135,000 Est. Cost $14.86 Unrealized —

AGIO AGIOS PHARMACEUTICALS INC 4.1%

Value ($000) $16,865 Shares 295,000 Est. Cost $53.23 Unrealized +18.2%

FATE FATE THERAPEUTICS INC 3.9%

Value ($000) $15,886 Shares 2,600,000 Est. Cost $4.33 Unrealized +3.1%

— SPARK THERAPEUTICS INC 3.8%

Value ($000) $15,553 Shares 302,474 Est. Cost $54.57 Unrealized —

CDXS CODEXIS INC 3.3%

Value ($000) $13,360 Shares 1,600,000 Est. Cost $4.93 Unrealized +40.4%

EVH EVOLENT HEALTH INC 3.2%

Value ($000) $13,253 Shares 1,077,500 Est. Cost $17.68 Unrealized -20.3%

— AUDENTES THERAPEUTICS INC 3.0%

Value ($000) $12,500 Shares 400,000 Est. Cost $17.77 Unrealized —

— GENMARK DIAGNOSTICS INC 2.8%

Value ($000) $11,384 Shares 2,730,000 Est. Cost $7.42 Unrealized —

ILMN ILLUMINA INC 2.3%

Value ($000) $9,614 Shares 44,000 Est. Cost $176.76 Unrealized +16.4%

— CLOVIS ONCOLOGY INC 2.1%

Value ($000) $8,670 Shares 127,500 Est. Cost $88.33 Unrealized —

— JOUNCE THERAPEUTICS INC 1.5%

Value ($000) $6,056 Shares 475,000 Est. Cost $16.79 Unrealized —

EDIT EDITAS MEDICINE INC 1.0%

Value ($000) $4,097 Shares 133,333 Est. Cost $20.61 Unrealized +22.2%

CTMX CYTOMX THERAPEUTICS INC 0.9%

Value ($000) $3,747 Shares 177,500 Est. Cost $15.07 Unrealized +37.6%

— SYROS PHARMACEUTICALS INC 0.6%

Value ($000) $2,667 Shares 274,074 Est. Cost $13.79 Unrealized —

GILD GILEAD SCIENCES INC 0.5%

Value ($000) $2,149 Shares 30,000 Est. Cost $55.90 Unrealized 0.0%

ONC BEIGENE LTD 0.4%

Value ($000) $1,759 Shares 18,000 Est. Cost $97.72 Unrealized —

OVID OVID THERAPEUTICS INC 0.4%

Value ($000) $1,579 Shares 160,000 Est. Cost $13.06 Unrealized -29.7%

AGIO AGIOS PHARMACEUTICALS INC 0.3%

Value ($000) $1,429 Shares 25,000 Est. Cost $53.23 Unrealized +18.2%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	SAGE THERAPEUTICS INC	250,000	$41,178	10.0%	$52.53	—	COM	78667J108
—	FOUNDATION MEDICINE INC	520,000	$35,464	8.6%	$22.74	—	COM	350465100
—	LOXO ONCOLOGY INC	360,000	$30,305	7.4%	$28.44	—	COM	548862101
—	BLUEPRINT MEDICINES CORP	348,000	$26,243	6.4%	$37.87	—	COM	09627Y109
—	BLUEBIRD BIO INC	145,000	$25,825	6.3%	$115.06	—	COM	09609G100
ALNY	ALNYLAM PHARMACEUTICALS INC	200,000	$25,410	6.2%	$73.35	+71.3%	COM	02043Q107
—	MYOKARDIA INC	560,000	$23,576	5.7%	$22.11	—	COM	62857M105
SGMO	SANGAMO THERAPEUTICS INC	1,400,000	$22,960	5.6%	$4.96	+200.2%	COM	800677106
—	GLOBAL BLOOD THERAPEUTICS IN	515,000	$20,265	4.9%	$29.83	—	COM	37890U108
VYGR	VOYAGER THERAPEUTICS INC	1,135,000	$18,841	4.6%	$14.86	—	COM	92915B106
AGIO	AGIOS PHARMACEUTICALS INC	295,000	$16,865	4.1%	$53.23	+18.2%	COM	00847X104
FATE	FATE THERAPEUTICS INC	2,600,000	$15,886	3.9%	$4.33	+3.1%	COM	31189P102
—	SPARK THERAPEUTICS INC	302,474	$15,553	3.8%	$54.57	—	COM	84652J103
CDXS	CODEXIS INC	1,600,000	$13,360	3.3%	$4.93	+40.4%	COM	192005106
EVH	EVOLENT HEALTH INC	1,077,500	$13,253	3.2%	$17.68	-20.3%	CL A	30050B101
—	AUDENTES THERAPEUTICS INC	400,000	$12,500	3.0%	$17.77	—	COM	05070R104
—	GENMARK DIAGNOSTICS INC	2,730,000	$11,384	2.8%	$7.42	—	COM	372309104
ILMN	ILLUMINA INC	44,000	$9,614	2.3%	$176.76	+16.4%	COM	452327109
—	CLOVIS ONCOLOGY INC	127,500	$8,670	2.1%	$88.33	—	COM	189464100
—	JOUNCE THERAPEUTICS INC	475,000	$6,056	1.5%	$16.79	—	COM	481116101
EDIT	EDITAS MEDICINE INC	133,333	$4,097	1.0%	$20.61	+22.2%	COM	28106W103
CTMX	CYTOMX THERAPEUTICS INC	177,500	$3,747	0.9%	$15.07	+37.6%	COM	23284F105
—	SYROS PHARMACEUTICALS INC	274,074	$2,667	0.6%	$13.79	—	COM	87184Q107
GILD	GILEAD SCIENCES INC	30,000	$2,149	0.5%	$55.90	0.0%	COM	375558103
ONC	BEIGENE LTD	18,000	$1,759	0.4%	$97.72	—	SPONSORED ADR	07725L102
OVID	OVID THERAPEUTICS INC	160,000	$1,579	0.4%	$13.06	-29.7%	COM	690469101
AGIO	AGIOS PHARMACEUTICALS INC	25,000	$1,429	0.3%	$53.23	+18.2%	Call	00847X104